Brandes Investment Partners, LP Takeda Pharmaceutical CO LTD Put Options Transaction History
Brandes Investment Partners, LP
- $10.5 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
369Shares Held
73.1MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$195 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$111 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$65.8 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$58.9 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.3MShares$48.3 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...